THE UNIVERSITY OF BRITISH COLUMBIA
THE UNIVERSITY OF BRITISH COLUMBIA
The Respiratory Evaluation Sciences Program (RESP) is a comprehensive epidemiology, health outcomes, and health economics program focused on chronic respiratory diseases (namely asthma and chronic obstructive pulmonary disease [COPD]).
We are hosted within Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, UBC. Our group has diverse expertise in using clinical data, real-world 'big' data, and computer simulations (disease modeling) techniques to evaluate the real-world effectiveness of health technologies and their 'value for money' potential. Our research has continuously been supported through multiple grants from CIHR and other agencies.
See more of our research by following categories:
Twenty-year trends in excess costs of chronic obstructive pulmonary disease
Respir J. 2024 Oct 28:2400516. doi: 10.1183/13993003.00516-2024. Epub ahead of print. PMID: 39467610.
Read more
RESA
Read more
Marginal versus conditional odds ratios when updating risk prediction models
Epidemiology. 2022 Jul 1;33(4):555-558. doi: 10.1097/EDE.0000000000001489.
Read more
Stay tuned!
RESP is hosted within Collaboration for Outcomes Research and Evaluation within UBC Faculty of Pharmaceutical Sciences. Our partners include UBC Division of Respiratory Medicine, and Centre for Clinical Epidemiology and Evaluation.
Our research has been funded by peer-reviewed grants from multiple institutions, including:
Respiratory Evaluation Sciences Program
2775 Laurel Street
7th Floor, Gordon and Leslie Diamond Health Care Centre
Vancouver, BC, Canada, V5Z 1M9
Principal Investigator: Mohsen Sadatsafavi
Tel: 604-875-4111 ext 66937
Fax: 604-875-5179
Email: msafavi@mail.ubc.ca
828 West 10th Avenue
7th Floor, Research Pavillion
Vancouver, BC, Canada, V5Z 1M9
